Dianne Murphy

1.6k total citations
28 papers, 1.1k citations indexed

About

Dianne Murphy is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Dianne Murphy has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pediatrics, Perinatology and Child Health, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Dianne Murphy's work include Pharmaceutical studies and practices (13 papers), Pharmaceutical Economics and Policy (4 papers) and Pediatric Pain Management Techniques (3 papers). Dianne Murphy is often cited by papers focused on Pharmaceutical studies and practices (13 papers), Pharmaceutical Economics and Policy (4 papers) and Pediatric Pain Management Techniques (3 papers). Dianne Murphy collaborates with scholars based in United States, Netherlands and Canada. Dianne Murphy's co-authors include William Rodriguez, Rosemary Roberts, Ann McMahon, Grace Chai, James P. Trinidad, Laura Governale, Judy A. Staffa, Jean Temeck, James K. Todd and Kenneth McIntosh and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PEDIATRICS.

In The Last Decade

Dianne Murphy

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dianne Murphy United States 15 584 190 184 161 138 28 1.1k
Helen Sammons United Kingdom 22 673 1.2× 123 0.6× 281 1.5× 156 1.0× 126 0.9× 73 1.5k
Daniel J. Cobaugh United States 25 238 0.4× 178 0.9× 83 0.5× 189 1.2× 196 1.4× 54 2.2k
Mark Naunton Australia 22 192 0.3× 123 0.6× 190 1.0× 128 0.8× 287 2.1× 125 1.7k
Hari Cheryl Sachs United States 14 477 0.8× 163 0.9× 60 0.3× 119 0.7× 60 0.4× 22 1.2k
Catharina C. M. Schuiling‐Veninga Netherlands 19 201 0.3× 164 0.9× 147 0.8× 299 1.9× 181 1.3× 64 1.3k
Marc Levine Canada 24 398 0.7× 93 0.5× 50 0.3× 138 0.9× 103 0.7× 61 1.7k
Alfred F.A.M. Schobben Netherlands 13 395 0.7× 78 0.4× 75 0.4× 191 1.2× 61 0.4× 19 959
Sharon Conroy United Kingdom 21 1.4k 2.4× 162 0.9× 364 2.0× 229 1.4× 527 3.8× 47 2.1k
Susan Frisbee‐Hume United States 23 485 0.8× 307 1.6× 139 0.8× 110 0.7× 131 0.9× 43 1.8k
Antje Neubert Germany 30 1.5k 2.5× 133 0.7× 357 1.9× 250 1.6× 377 2.7× 100 2.4k

Countries citing papers authored by Dianne Murphy

Since Specialization
Citations

This map shows the geographic impact of Dianne Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dianne Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dianne Murphy more than expected).

Fields of papers citing papers by Dianne Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dianne Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dianne Murphy. The network helps show where Dianne Murphy may publish in the future.

Co-authorship network of co-authors of Dianne Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Dianne Murphy. A scholar is included among the top collaborators of Dianne Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dianne Murphy. Dianne Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sun, Haihao, et al.. (2017). Extrapolation of Efficacy in Pediatric Drug Development and Evidence-based Medicine: Progress and Lessons Learned. Therapeutic Innovation & Regulatory Science. 52(2). 199–205. 49 indexed citations
3.
Tomasi, P., et al.. (2017). Pediatric Medicine Development: An Overview and Comparison of Regulatory Processes in the European Union and United States. Therapeutic Innovation & Regulatory Science. 51(3). 360–371. 49 indexed citations
5.
Sun, Haiming, Peter G. Como, L. Corbin Downey, et al.. (2015). Infant formula and neurocognitive outcomes: impact of study end-point selection. Journal of Perinatology. 35(10). 867–874. 13 indexed citations
6.
Sun, Haihao, E. Bastings, Jean Temeck, et al.. (2013). Migraine Therapeutics in Adolescents. JAMA Pediatrics. 167(3). 243–243. 40 indexed citations
7.
Chai, Grace, Laura Governale, Ann McMahon, et al.. (2012). Trends of Outpatient Prescription Drug Utilization in US Children, 2002–2010. PEDIATRICS. 130(1). 23–31. 272 indexed citations
8.
McMahon, Ann, Mark Levenson, Bradley McEvoy, Andrew D. Mosholder, & Dianne Murphy. (2011). Age and Risks of FDA-Approved Long-Acting β2-Adrenergic Receptor Agonists. PEDIATRICS. 128(5). e1147–e1154. 60 indexed citations
9.
DeVeaugh-Geiss, Joseph, John S. March, Mark Shapiro, et al.. (2006). Child and Adolescent Psychopharmacology in the New Millennium: A Workshop for Academia, Industry, and Government. Journal of the American Academy of Child & Adolescent Psychiatry. 45(3). 261–270. 23 indexed citations
10.
Meyerhoff, Allen S., et al.. (2004). US Food and Drug Administration Approval of Ciprofloxacin Hydrochloride for Management of Postexposure Inhalational Anthrax. Clinical Infectious Diseases. 39(3). 303–308. 33 indexed citations
11.
Shaffer, Douglas, Karen M. Higgins, Peter K. Honig, et al.. (2003). Increased US prescription trends associated with the CDC Bacillus anthracis antimicrobial postexposure prophylaxis campaign. Pharmacoepidemiology and Drug Safety. 12(3). 177–182. 18 indexed citations
12.
Rodriguez, William, Rosemary Roberts, & Dianne Murphy. (2003). Current Regulatory Policies Regarding Pediatric Indications and Exclusivity. Journal of Pediatric Gastroenterology and Nutrition. 37(Supplement 1). S40–S45. 9 indexed citations
13.
Roberts, Rosemary, et al.. (2003). Pediatric Drug Labeling. JAMA. 290(7). 905–905. 228 indexed citations
14.
Rodriguez, William J., Rosemary Roberts, & Dianne Murphy. (2001). Adverse drug events in children: the US Food and Drug Administration perspective. Current Therapeutic Research. 62(10). 711–723. 17 indexed citations
15.
Kearns, Gregory L., et al.. (1994). Paediatric Labelling Requirements. Clinical Pharmacokinetics. 26(4). 308–325. 30 indexed citations
16.
Murphy, Dianne. (1993). Women in clinical trials: HIV-infected women.. PubMed. 48(2). 175–9. 2 indexed citations
17.
Murphy, Dianne, et al.. (1981). The use of gowns and masks to control respiratory illness in pediatric hospital personnel. The Journal of Pediatrics. 99(5). 746–750. 65 indexed citations
18.
Murphy, Dianne. (1980). Pneumococcal Empyema. American journal of diseases of children. 134(7). 659–659. 25 indexed citations
19.
Murphy, Dianne, et al.. (1979). Actinomycosis from a toothpick injury. The Journal of Pediatrics. 94(6). 925–927. 5 indexed citations
20.
Murphy, Dianne & James K. Todd. (1979). Treatment of ampicillin-resistant Haemophilus influenzae in soft tissue infections with high doses of ampicillin. The Journal of Pediatrics. 94(6). 983–987. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026